NOVACYT (ALNOV.PA) Stock Price, Forecast & Analysis
Europe - Euronext Paris - EPA:ALNOV - FR0010397232 - Common Stock
ALNOV.PA Key Statistics, Chart & Performance
The current stock price of ALNOV.PA is 0.419 EUR. In the past month the price increased by 4.23%. In the past year, price decreased by -34.12%.
ALNOV.PA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ALNOV.PA. When comparing the yearly performance of all stocks, ALNOV.PA is a bad performer in the overall market: 91.03% of all stocks are doing better.
ALNOV.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALNOV.PA. ALNOV.PA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
ALNOV.PA Financial Highlights
Over the last trailing twelve months ALNOV.PA reported a non-GAAP Earnings per Share(EPS) of -0.5. The EPS increased by 17.85% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -48.32% | ||
| ROE | -74.44% | ||
| Debt/Equity | 0.24 |
ALNOV.PA Forecast & Estimates
ALNOV.PA Ownership
About ALNOV.PA
Company Profile
Novacyt SAS is a diagnostics company, which engages in the business of developing, producing, and selling vitro and molecular diagnostic tests and products for a wide range of infectious diseases. The company is headquartered in Velizy-Villacoublay, Ile-De-France and currently employs 234 full-time employees. The company went IPO on 2012-10-12. The firm develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. The company provides diagnostic products used in oncology, microbiology, haematology, and serology testing. The firm develops secure automated cytology named NovaPrep Processor System. The company offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. The company creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle.
Company Info
NOVACYT
131 Boulevard Carnot, Le Vesinet
Velizy-Villacoublay ILE-DE-FRANCE FR
Employees: 240
Phone: 33139465104
NOVACYT / ALNOV.PA FAQ
What does NOVACYT do?
Novacyt SAS is a diagnostics company, which engages in the business of developing, producing, and selling vitro and molecular diagnostic tests and products for a wide range of infectious diseases. The company is headquartered in Velizy-Villacoublay, Ile-De-France and currently employs 234 full-time employees. The company went IPO on 2012-10-12. The firm develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. The company provides diagnostic products used in oncology, microbiology, haematology, and serology testing. The firm develops secure automated cytology named NovaPrep Processor System. The company offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. The company creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle.
Can you provide the latest stock price for NOVACYT?
The current stock price of ALNOV.PA is 0.419 EUR.
What is the dividend status of NOVACYT?
ALNOV.PA does not pay a dividend.
How is the ChartMill rating for NOVACYT?
ALNOV.PA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists ALNOV stock?
ALNOV.PA stock is listed on the Euronext Paris exchange.
Can you provide the sector and industry classification for NOVACYT?
NOVACYT (ALNOV.PA) operates in the Health Care sector and the Biotechnology industry.
Who owns NOVACYT?
You can find the ownership structure of NOVACYT (ALNOV.PA) on the Ownership tab.